These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3312703)

  • 21. Parenteral augmentin: pharmacokinetics.
    Staniforth DH; Jackson D; Horton R; Davies B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):430-4. PubMed ID: 6490225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical study of BRL 25000 (clavulanic acid-amoxicillin) granules in pediatric infections].
    Nagamatsu I; Horiguchi S; Hatae T
    Jpn J Antibiot; 1985 Feb; 38(2):287-95. PubMed ID: 3847518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Toyonaga Y; Kurosu Y; Sugita M; Nakamura H; Takahashi T; Hori M
    Jpn J Antibiot; 1985 Feb; 38(2):373-413. PubMed ID: 3847524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Is there in Belgium an increase in resistance to the combination amoxicillin/clavulanic acid of Escherichia coli as reference bacteria?].
    Yourassowsky E; Van der Linden MP; MacGilavry GB; Glupczynsky Y
    Acta Clin Belg; 1992; 47(1):15-20. PubMed ID: 1317079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Appearance of Escherichia coli strain with high production of cephalosporinase during treatment with an amoxicillin and clavulanic acid combination].
    Aubert G; Peyle V; Dumont N; el Fassi M; Dorche G
    Ann Biol Clin (Paris); 1990; 48(7):449-54. PubMed ID: 2278408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A clinico-laboratory assessment of the efficacy of an Augmentin suspension in treating children with suppurative-inflammatory diseases caused by opportunistic bacteria].
    Savitskaia KI; Nekhorosheva AG; Skala LZ; Nasonov VN; Solodilova OE; Shanina AG; Dutova EN
    Antibiot Khimioter; 1992 Sep; 37(9):29-33. PubMed ID: 1444666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Problems associated with susceptibility testing of co-amoxiclav.
    Ellis R; Andrews J; Wise R
    J Antimicrob Chemother; 1993 Mar; 31(3):443-5. PubMed ID: 8486581
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experimental and clinical studies on BRL 25000 (clavulanic acid-amoxicillin) in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1985 Feb; 38(2):342-58. PubMed ID: 3847522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of sensitivity of Mycobacterium spp. to combinations of clavulanic acid & penicillins with certain antitubercular agents.
    Bhattacharya CP; Charkrabarty AN; Dastidar SG
    Indian J Med Res; 1988 Aug; 88():118-23. PubMed ID: 3198169
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bactericide activity of cefadroxil comparated with amoxicillin-clavulanic acid, cefaclor and josamycin].
    Etesse-Carsenti H; Caillon J; Mondain V; Durant J; Bernard E; Dellamonica P; Drugeon HB
    Pathol Biol (Paris); 1991 Sep; 39(7):658-67. PubMed ID: 1758716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The antimicrobial activity of Augmentin (amoxicillin/clavulanic acid) compared to other antibacterial agents].
    Zubkov MN; Nonikov VE; Gugutsidze EN; Sutormina TM; Makarova OV
    Antibiot Khimioter; 1992 Sep; 37(9):34-6. PubMed ID: 1444669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microcalorimetric, turbidimetric, phase-contrast microscopic, and electron microscopic investigations of the actions of amoxicillin, clavulanic acid and augmentin on amoxicillin-sensitive and amoxicillin-resistant strains of Escherichia coli.
    Semenitz E; Casey PA; Pfaller W; Gstraunthaler G
    Chemotherapy; 1983; 29(3):192-207. PubMed ID: 6347546
    [No Abstract]   [Full Text] [Related]  

  • 33. The antibacterial activity of co-amoxiclav.
    Barry AL; Pfaller MA; Fuchs PC
    J Antimicrob Chemother; 1993 Apr; 31(4):612-5. PubMed ID: 8514658
    [No Abstract]   [Full Text] [Related]  

  • 34. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
    Sedallian A; Roudon T
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of enteric pathogens to amoxicillin and clavulanate-potentiated amoxicillin.
    Mégraud F; Gavinet A
    Chemioterapia; 1987 Jun; 6(2 Suppl):75-6. PubMed ID: 3334666
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential sensitivities to amoxycillin/clavulanate and amoxycillin in general practice urinary infections.
    Brumfitt W; Hamilton-Miller JM
    Lancet; 1983 Sep; 2(8349):566. PubMed ID: 6136712
    [No Abstract]   [Full Text] [Related]  

  • 37. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nishimura T; Tabuki K; Takashima T; Takagi M
    Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clavulanic acid/antibiotic ratios.
    Rolinson GN
    J Antimicrob Chemother; 1985 Feb; 15(2):256-7. PubMed ID: 3980316
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative pharmacokinetics of amoxicillin/clavulanic acid combination after intravenous administration to sheep and goats.
    Carceles CM; Escudero E; Baggot JD
    J Vet Pharmacol Ther; 1995 Apr; 18(2):132-6. PubMed ID: 7629927
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Nishiyama T; Ishimoto K; Tominaga K; Iriki T; Harada M
    Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.